Can live attenuated virus work as post-exposure treatment?
- 31 March 1995
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 16 (3) , 131-135
- https://doi.org/10.1016/0167-5699(95)80129-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Primate models for HIV vaccinesAIDS, 1993
- Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef GeneScience, 1992
- Vaccine Protection of Chimpanzees Against Challenge with HIV-1-Infected Peripheral Blood Mononuclear CellsScience, 1992
- AIDS vaccine developmentsNature, 1992
- Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160Science, 1992
- Anti-cell antibody in macaquesNature, 1991
- Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences.Proceedings of the National Academy of Sciences, 1991
- Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.Proceedings of the National Academy of Sciences, 1991
- Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160Nature, 1990
- Vaccine protection against simian immunodeficiency virus infection.Proceedings of the National Academy of Sciences, 1989